<DOC>
	<DOCNO>NCT01257139</DOCNO>
	<brief_summary>This phase III randomize multicenter study involve subject 70 year age non small-cell lung cancer IV PS 0 , 1 2 , previously receive chemotherapy . The aim validate use simplify geriatric scale ( SGS ) screen tool . If SGS result normal , patient treat dual-agent therapy base platinum ( carboplatin + pemetrexed histology non epidermoid , carboplatin + gemcitabin histology epidermoid ) , geriatric assessment . When SGS reveal abnormality , comprehensive geriatric evaluation ( CGE ) use define two subpopulation Balducci 's fragility scale , receive either monotherapy ( docetaxel ) best supportive care . The strategy base SGS compare treatment algorithm base standard criterion ( PS age ) , specific geriatric assessment . The main endpoint time treatment failure . The SGS compose Charlson co-morbidity scale , functional assessment base PS , Katz ' ADL scale , Lawton 's simplified IADL scale , simplify cognitive assessment mini-MMSE accord Schultz-Larsen , geriatric depression scale ( GDS 5 ) , screen geriatric syndrome define existence dementia , repeat fall , urinary fecal incontinence . The SGS validate comparison CGE , administer systematically enrollment . All SGS item include CGE . Secondary endpoint quality life ( measure LCSS EuroQoL questionnaire ) , overall survival , objective response rate , toxicity . The investigator also study predictive power nutritional index PINI Buzby score respect survival , treatment response , tolerability .</brief_summary>
	<brief_title>Trial Involving Subjects Over 70 Years Age With Non Small-cell Lung Cancer Stage IV Comparing `` Classical '' Strategy Treatment Allocation , With '' Optimized '' Strategy Allocating Same Treatments</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Cytologically histologically proven NSCLC ( adenocarcinoma , epidermoid carcinoma , largecell carcinoma ) stage IV histologically cytologically proven pleurisy neoplastic pericarditis . No previous systemic chemotherapy lung cancer . Presence least one measurable target lesion ( RECIST rule ) non irradiated region . Age strictly least 70 year . PS 0 , 1 2 . Life expectancy sup 12 week . Creatinine clearance least 45 ml per min MDRD Formula ( Modification Diet Renal Disease ) . Normal hematologic function : absolute polymorphonuclear neutrophil count &gt; 1.5 . 109 per l platelet sup 100 . 109/l , hemoglobin sup 9.5 g per dl Normal hepatic function : bilirubin inf 1.5 x normal , SGOT SGPT inf 2.5 . normal . Patients metastatic relapse ( cytologically histologically prove ) primary lung cancer non irradiate region , surgical excision local external radiotherapy . Prior irradiation authorize involve less 25 percent total bone marrow volume . Men must surgically sterile must accept use effective contraceptive methodall along 6 month treatment period Signed write informed consent . Other severe concurrent disorder occur prior six month enrollment ( myocardial infection , severe unstable angor , coronarian peripheric arterial bypass operation , NYHA class 3 4 congestive heart failure , transient constitute cerebral ischemic attack , least grade 2 peripheral neuropathy , stomach ulcer , erosive oesophagitis gastritis , psychiatric neurological disorder prevent patient understand trial , uncontrolled infection ) . Another previous concomitant cancer , except basocellular cancer skin treat cervical cancer situ , appropriately treat localize lowgrade prostate cancer ( Gleason score inf 6 ) , unless initial tumor diagnose definitively treat 5 year previously , evidence relapse . Bronchoalveolar neuroendocrine composite cancer Superior caval syndrome . Presence symptomatic brain metastasis . Peripheral neuropathy ( grade sup 2 ) . Performance status sup 2 ( ECOG ) . A significant third liquid part ( example ascitis pleural effusion ) hat ca n't control drainage procedure enrollment Impossibility stop treatment aspirin ( dose 1.3 mg per day ) NSAI 5 day ( 8 day molecule long period action like piroxicam Concurrent participation another clinical trial . Definitive contraindication steroid folic acid vitamin B12 histology nonepidermoid . All concurrent radiotherapy , except local palliative bone radiotherapy . Concurrent administration one several antitumor therapy . Recent vaccination yellow fever ( 30 day enrollment ) Psychological , familial , social geographic difficulty prevent followup define protocol . Administrative legal detention . Contraindication study drug . Concurrent participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>To evaluate geriatric scale design help treatment</keyword>
	<keyword>allocation dual-agent therapy base platinum</keyword>
	<keyword>single-agent chemotherapy elderly subject advancedstage</keyword>
	<keyword>NSCLC , base time failure two arm</keyword>
</DOC>